Key insights
- Charles Schwab's co-chairman sold $2.54M in SCHW stock. Despite the sale, analysts have recently raised price targets, citing improved revenue guidance and confidence in the company's growth. The stock is trading near its 52-week low, but analyst ratings remain broadly positive. The insider selling creates a slightly negative signal, offset by positive analyst outlook.
Charles R. Schwab, Co-Chairman of Charles Schwab Corp. (NASDAQ:SCHW), sold 27,500 shares of the company’s common stock on May 19, 2026. The shares were sold at prices ranging from $91.95 to $92.54, with a weighted average sale price of $92.2228 per share. This transaction amounted to a total value of $2,536,127.The sale comes as the stock trades at $90.11, near its 52-week low and below InvestingPro’s Fair Value analysis, suggesting the shares may be undervalued. The company maintains a market capitalization of $156.35 billion and a P/E ratio of 17.94.
The sale was executed indirectly by a Limited Partnership. Following this transaction, the Limited Partnership indirectly holds 30,209,768 shares of Charles Schwab common stock.
Mr. Schwab also has other indirect holdings in the company. These include 54,384,341 shares held by a Trust, 44,025 shares held by 188 Corp, and 10,624,797.33 shares held by a Spouse as Trustee.
In other recent news, Charles Schwab has been the focus of several analyst firms following its 2026 Investor Day. TD Cowen raised its price target for Charles Schwab to $109, maintaining a Buy rating, and adjusted its earnings per share estimates for 2026 and 2027. Piper Sandler also increased its price target to $105, citing an improved revenue guidance driven by expected net interest margin growth by year-end, while keeping a Neutral rating. Citizens reiterated its Market Outperform rating with a $120 price target, expressing confidence in the company’s expanding growth algorithm. Barclays raised its price target to $127, maintaining an Overweight rating, and noted that Charles Schwab has no plans to introduce AI-powered cash optimization tools, which management does not see as a threat. Raymond James also increased its price target to $137, maintaining an Outperform rating. These updates reflect a broadly positive outlook from analysts on Charles Schwab’s future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.